The initial experience of COVID-19 vaccination in autoimmune blistering diseases patients from a reference care center in Italy

Dermatol Ther. 2021 Sep;34(5):e15057. doi: 10.1111/dth.15057. Epub 2021 Jul 14.

Authors

Federico Bardazzi¹, Diego Abbenante¹, Federica Filippi¹, Lidia Sacchelli¹, Camilla Loi¹

Affiliation

¹ Division of Dermatology, IRCCS Azienda Ospedaliero, Universitaria di Bologna, Bologna, Italy.

No abstract available

Publication types

Letter

MeSH terms

Autoimmune Diseases*
COVID-19 Vaccines
COVID-19*
Humans
Italy
SARS-CoV-2
Vaccination

Substances

COVID-19 Vaccines